clinical trial · NCT00648882
Fasting Study of Levothyroxine Sodium Tablets 300 mcg to Synthroid® Tablets 300 mcg
HealthyLEVOTHYROXINE SODIUM TABLETS,SYNTHROID® 300 mcg Tablets
brief summary
The objective of this study was to investigate the bioequivalence of Mylan's levothyroxine sodium 300 mcg tablets to Abbott's Synthroid® 300 mcg tablets following a single, oral 600 mcg dose (2 × 300 mcg) administered under fasting conditions.
started
Mar 1, 2007
primary completion
Apr 1, 2007
completion
May 1, 2007
last updated
Apr 24, 2024
official title
Single-Dose Fasting Bioequivalence Study of Levothyroxine Sodium Tablets (300 mcg; Mylan) to Synthroid® Tablets (300 mcg; Abbott)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol